Statins lack primary prevention benefit in elderly: study

Statins provide no benefit for primary cardiovascular prevention in patients older than 65, a study suggests.

A post-hoc analysis of data from the ALLHAT-LLT trial shows pravastatin sodium at 40mg/day is not associated with any improvement over usual care for rates of coronary heart disease or all-cause mortality.

And among people older than 75, there’s a non-significant trend towards higher all-cause mortality, researchers